ANGO — AngioDynamics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for AngioDynamics, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

	2022 May 31st	2023 May 31st	2024 May 31st	2025 May 31st	2026 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	28.8	44.6	76.1	55.9	53.9
Net Total Accounts Receivable
Net Total Receivables	52.3	52.8	50	43.1	48.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	143	164	193	168	163
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	52	49.5	41.5	36.1	32.1
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	553	533	318	280	267
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	74.3	83.8	91.2	76.2	74.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	128	154	112	97.2	96.3
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	424	378	206	183	171
Total Liabilities & Shareholders' Equity	553	533	318	280	267
Total Common Shares Outstanding